Blood Collection Tubes Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Blood Collection Tubes Market
Blood Collection Tubes Market: By Type (Plasma Separation Tube, Heparin Tubes, Serum Separating Tubes, EDTA Tubes, Rapid Serum Tubes and Others); and By Geography - Forecast(2018 - 2023)
Report Code : HCR 0161
Updated Date: 31 May, 2018  

1. Blood Collection Tubes – Market Overview
2. Executive Summary 
3. Blood Collection Tubes Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Blood Collection Tubes – Market Forces
   4.1. Drivers
      4.1.1. Increasing government initiatives
      4.1.2. Rise in the demand for blood and blood components
   4.2. Restraints
      4.2.1. The research and development having higher cost
   4.3. Opportunities
      4.3.1. Increasing number of complex surgeries in emerging economies
      4.3.2. Rise in aging population and prevalence of diseases
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Blood Collection Tubes Market, By Type 
   5.1. Plasma Separation Tube
   5.2. Heparin Tubes
   5.3. Serum Separating Tubes
   5.4. EDTA Tubes
   5.5. Rapid Serum Tubes
   5.6. Others
6. Blood Collection Tubes Market, By Geography
   6.1. Europe
      6.1.1. Germany
      6.1.2. France
      6.1.3. Italy
      6.1.4. Spain
      6.1.5. Russia
      6.1.6. U.K.
      6.1.7. Rest of Europe
   6.2. Asia Pacific
      6.2.1. China
      6.2.2. India
      6.2.3. Japan
      6.2.4. South Korea
      6.2.5. Rest of Asia-Pacific
   6.3. North America 
      6.3.1. U.S.
      6.3.2. Canada
      6.3.3. Mexico
   6.4. Rest of the World (RoW)
      6.4.1. Brazil
      6.4.2. Rest of RoW
7. Blood Collection Tubes – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions, and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles 
   8.1. Becton Dickinson & Company
      8.1.1. Introduction
      8.1.2. Financials
      8.1.3. Key Insights
      8.1.4. Key Strategy
      8.1.5. Product Portfolio
      8.1.6. SWOT Analysis
   8.2. Immucor, Inc.
      8.2.1. Introduction
      8.2.2. Financials
      8.2.3. Key Insights
      8.2.4. Key Strategy
      8.2.5. Product Portfolio
      8.2.6. SWOT Analysis
   8.3. Greiner Group AG
      8.3.1. Introduction
      8.3.2. Financials
      8.3.3. Key Insights
      8.3.4. Key Strategy
      8.3.5. Product Portfolio
      8.3.6. SWOT Analysis
   8.4. Sarstedt AG & Co.
      8.4.1. Introduction
      8.4.2. Financials
      8.4.3. Key Insights
      8.4.4. Key Strategy
      8.4.5. Product Portfolio
      8.4.6. SWOT Analysis
   8.5. QIAGEN N.V.
      8.5.1. Introduction
      8.5.2. Financials
      8.5.3. Key Insights
      8.5.4. Key Strategy
      8.5.5. Product Portfolio
      8.5.6. SWOT Analysis
   8.6. Terumo Corporation
      8.6.1. Introduction
      8.6.2. Financials
      8.6.3. Key Insights
      8.6.4. Key Strategy
      8.6.5. Product Portfolio
      8.6.6. SWOT Analysis
   8.7. FL Medical srl
      8.7.1. Introduction
      8.7.2. Financials
      8.7.3. Key Insights
      8.7.4. Key Strategy 
      8.7.5. Product Portfolio
      8.7.6. SWOT Analysis
   8.8. Haemonetics Corporation
      8.8.1. Introduction
      8.8.2. Financials
      8.8.3. Key Insights
      8.8.4. Key Strategy
      8.8.5. Product Portfolio
      8.8.6. SWOT Analysis
   8.9. Beckman Coulter, Inc.
      8.9.1. Introduction
      8.9.2. Financials
      8.9.3. Key Insights
      8.9.4. Key Strategy
      8.9.5. Product Portfolio
      8.9.6. SWOT Analysis
   8.10. AdvaCare Pharmaceuticals
      8.10.1. Introduction
      8.10.2. Financials
      8.10.3. Key Insights
      8.10.4. Key Strategy
      8.10.5. Product Portfolio
      8.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix
   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Bibliography
   9.5. Compilation of Expert Insights
   9.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll